Actuate Therapeutics ACTU
NASDAQ ACTU
$1.27 +0.04 (+3.25%)
At close: Aug 21, 2026 · 4:00 PM EDT

Actuate Therapeutics (ACTU) Treasury Shares (2024 - 2025)

Actuate Therapeutics (ACTU) posted quarterly Treasury Shares of $617236.0 for Q4 2025, up 13.44% year-over-year from $544111.0 in Q4 2024, and up 2964.42% quarter-over-quarter from $20142.0 in Q3 2025.

Actuate Therapeutics (ACTU) Treasury Shares (2024 - 2025) Analysis & Trends

Actuate Therapeutics (ACTU) has reported Treasury Shares for 2 consecutive years, with $617236.0 the latest figure, recorded in Q4 2025.

  • In Q4 2025, Treasury Shares rose 13.44% year-over-year to $617236.0; the TTM figure through Dec 2025 stood at $617236.0 (up 13.44% YoY), while the FY2025 annual figure was $617236.0, up 13.44% from the prior year.
  • Treasury Shares rose to $617236.0 in Q4 2025 per ACTU's latest filing, from $20142.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $24.7 million in Q2 2024 and bottomed at $20142.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 36.40 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 8.96 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - 2.72 Mn
10 Actuate Therapeutics 30.08 Mn 30.08 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 617,236.00
Dec 31, 2025 617,236.00
Sep 30, 2025 20,142.00
Sep 30, 2025 20,142.00
Jun 30, 2025 584,111.00
Jun 30, 2025 584,111.00
Mar 31, 2025 584,111.00
Mar 31, 2025 584,111.00
Dec 31, 2024 544,111.00
Dec 31, 2024 544,111.00
Sep 30, 2024 544,111.00
Sep 30, 2024 544,111.00
Jun 30, 2024 24.68 Mn
Jun 30, 2024 24.68 Mn